Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,93 USD | +4,89% | +4,32% | +36,88% |
Attività
Numero di dipendenti: 83
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Germany
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/06/18 |
Srinivas Rao
FOU | Founder | 55 | 01/06/18 |
Anne Johnson
DFI | Director of Finance/CFO | - | 01/01/21 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/01/21 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Michael Raven
COO | Chief Operating Officer | - | 01/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/01/21 |
Founder | 46 | 01/06/18 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/01/21 |
Jason Camm
BRD | Director/Board Member | 35 | 01/01/22 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 166 026 396 | 149 440 170 ( 90,01 %) | 0 | 90,01 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21.36% | 37 300 000 | 21.36% | 6 564 800 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+36,88% | 323 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione ATAI
- Società Atai Life Sciences N.V.